SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 80 filers reported holding SYNERON MEDICAL LTD in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $2,103,000 | +1320.9% | 192,100 | +1272.1% | 0.01% | +1100.0% |
Q1 2017 | $148,000 | +25.4% | 14,000 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $118,000 | +18.0% | 14,000 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $100,000 | -7.4% | 14,000 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $108,000 | +5.9% | 14,000 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $102,000 | -5.6% | 14,000 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $108,000 | +8.0% | 14,000 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $100,000 | -32.9% | 14,000 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $149,000 | -13.9% | 14,000 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $173,000 | +32.1% | 14,000 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $131,000 | -6.4% | 14,000 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $140,000 | -2.8% | 14,000 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $144,000 | -17.2% | 14,000 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $174,000 | +1.2% | 14,000 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $172,000 | +42.1% | 14,000 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $121,000 | -0.8% | 14,000 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $122,000 | – | 14,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NORTH TIDE CAPITAL, LLC | 2,350,000 | $28,905,000 | 2.53% |
HOURGLASS CAPITAL, LLC | 838,900 | $10,318,000 | 1.65% |
Baupost Group | 4,000,000 | $49,200,000 | 1.39% |
DAFNA Capital Management LLC | 90,947 | $1,119,000 | 1.15% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 625,567 | $7,694,000 | 1.04% |
Visium Asset Management, LP | 3,405,000 | $41,882,000 | 0.82% |
PERRITT CAPITAL MANAGEMENT INC | 400,000 | $4,920,000 | 0.82% |
Leonard Capital Management, Inc. | 112,109 | $1,379,000 | 0.54% |
BRANDES INVESTMENT PARTNERS, LP | 2,164,137 | $26,619,000 | 0.33% |
Broadfin Capital, LLC | 200,000 | $2,460,000 | 0.32% |